Cargando…
IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma
BACKGROUND: The differential diagnosis of endometrial stromal tumor (EST) and uterine cellular leiomyoma (CL) remains a challenge in clinical practice, especially low grade endometrial stromal sarcoma (ESS) and CL, suggesting the need for novel immunomarkers panels for differential diagnosis. Interf...
Autores principales: | Zhao, Weilin, Cui, Mei, Zhang, Ruiqi, Shen, Xihua, Xiong, Xin, Ji, Xinhua, Tao, Lin, Jia, Wei, Pang, Lijuan, Sun, Zhenzhu, Wang, Chun, Zou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461929/ https://www.ncbi.nlm.nih.gov/pubmed/34556086 http://dx.doi.org/10.1186/s12885-021-08781-w |
Ejemplares similares
-
Cellular leiomyoma versus endometrial stromal tumor: A pathologists' dilemma
por: Pujani, Mukta, et al.
Publicado: (2015) -
Caldesmon: Biochemical and Clinical Implications in Cancer
por: Yao, Yi-Bo, et al.
Publicado: (2021) -
IFITM proteins — cellular inhibitors of viral entry
por: Smith, SE, et al.
Publicado: (2014) -
Identification by monoclonal antibodies and characterization of human platelet caldesmon
Publicado: (1986) -
Localization of caldesmon and its dephosphorylation during cell division
Publicado: (1993)